# Evoke Pharma Inc

Evoke Pharma Inc is a company headquartered in Solana Beach, CA, United States.

## Company overview

- **Legal name:** Evoke Pharma Inc
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Solana Beach, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001403708

## About

Evoke Pharma Inc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001403708, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-13, it reported annual revenue of USD 10,249,415; net income of USD -5,352,194; total assets of USD 17,519,007 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $10.2M (USD 10,249,415)
- **Net income:** -$5.4M (USD -5,352,194)
- **Total assets:** $17.5M (USD 17,519,007)
- **Cash and equivalents:** $13.6M (USD 13,596,600)
- **Operating cash flow:** -$5.5M (USD -5,458,742)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $5.2M (USD 5,180,630)
- **Net income:** -$7.8M (USD -7,792,295)
- **Total assets:** $7.1M (USD 7,068,546)
- **Cash and equivalents:** $4.7M (USD 4,739,426)
- **Operating cash flow:** -$5.0M (USD -4,984,977)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $2.5M (USD 2,508,645)
- **Net income:** -$8.2M (USD -8,224,130)
- **Total assets:** $11.9M (USD 11,851,488)
- **Cash and equivalents:** $9.8M (USD 9,843,699)
- **Operating cash flow:** -$6.6M (USD -6,595,987)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $1.6M (USD 1,618,076)
- **Net income:** -$8.5M (USD -8,537,952)
- **Total assets:** $10.6M (USD 10,573,162)
- **Cash and equivalents:** $9.1M (USD 9,144,710)
- **Operating cash flow:** -$12.4M (USD -12,352,944)

## Recent SEC filings

- Form 8-K — filed 2025-12-17 — period 2025-12-17 — 8-K
- Form 8-K — filed 2025-11-13 — period 2025-11-13 — 8-K
- Form 10-Q — filed 2025-11-13 — period 2025-09-30 — 10-Q
- Form 8-K — filed 2025-11-04 — period 2025-10-29 — 8-K
- Form 8-K — filed 2025-08-14 — period 2025-08-14 — 8-K
- Form 10-Q — filed 2025-08-14 — period 2025-06-30 — 10-Q
- Form 8-K — filed 2025-08-06 — period 2025-08-06 — 8-K
- Form 8-K — filed 2025-07-09 — period 2025-07-09 — 8-K
- Form 8-K — filed 2025-05-22 — period 2025-05-21 — 8-K
- Form 10-Q — filed 2025-05-13 — period 2025-03-31 — 10-Q
- Form 8-K — filed 2025-05-13 — period 2025-05-13 — 8-K
- Form DEF 14A — filed 2025-04-10 — period 2025-05-21 — DEF 14A

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/evoke-pharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology